Elarcosa, Millet M.

HRN: 14-40-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
AMPICILLIN 1GM (VIAL)
08/15/2023
08/17/2023
IV
2gms
Q6H
PROM
Checking Final Appropriateness 
08/15/2023
CEFUROXIME 500MG (TAB)
08/15/2023
08/22/2023
PO
500mg
BID
S/P NSVD WITH RMLE
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: